MitraClip for the treatment of mitral regurgitation

doi:10.4414/cvm.2012.00103

Cited by 5 publications

(2 citation statements)

References 46 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…EVEREST II compared TEER with conventional surgery in a 12-month-follow-up and revealed that it was superior to the surgery when safety is considered. Despite being less efficient at reducing MR, the improvement of clinical outcome after TEER was comparable to classic surgery [9,26]. It proved that TEER with the MitraClip is an effective and relatively safe procedure in comparison to the surgical mitral valve repair or optimal medical treatment [20,27].…”

Section: Clinical Evidence Regarding the Efficacy Of Mitraclipmentioning

confidence: 88%

“…As speculated before, with the development of technology, the number of postprocedural complications decreases and the clinical outcomes are satisfactory [2,18,19,26,34]. It was proven that edge-to-edge intervention is related with persistent reduction of the severity of MR at 1-year follow-up [32] and a high, immediate improvement of patients' qualify of life [11,34].…”

Section: Future Directions and Conclusionmentioning

confidence: 98%

See 1 more Smart Citation

Complications following transcatheter edge-to-edge mitral valve repair: Personal experience and review of the literature

et al. 2023

View full text Add to dashboard Cite

Mitral valve dysfunction affects around 2% of the population and its incidence is still increasing, making it the second most common valvular heart disease, after aortic stenosis. Depending on the etiology of the disease, it can be classified into primary or secondary mitral regurgitation. The first line of treatment is optimal medical therapy. If ineffective, mitral valve intervention can be considered. For patients disqualified from surgical treatment, transcatheter edge-to-edge repair with the use of MitraClip may be considered. Over 100,000 MitraClip procedures have been performed which makes this the most established transcatheter technique for the treatment of severe mitral regurgitation. The aim of this review is to discuss the technical details of the MitraClip procedure, clinical evidence regarding the efficacy of MitraClip, complications related to the clip implantation alongside with acute complications based on the currently available evidence and clinical experience.

show abstract

Section: Clinical Evidence Regarding the Efficacy Of Mitraclipmentioning

confidence: 88%

Section: Future Directions and Conclusionmentioning

confidence: 98%

Complications following transcatheter edge-to-edge mitral valve repair: Personal experience and review of the literature

et al. 2023

View full text Add to dashboard Cite

show abstract

Operative Techniken bei Mitralklappenerkrankungen

Noack

Mohr

2015

Herz

View full text Add to dashboard Cite

Mitral valve (MV) disease is one of the most common heart valve diseases. The surgical and interventional treatment for MV disease requires a multidisciplinary approach. For primary mitral valve regurgitation (MVR) surgical MV repair is the treatment of choice, which can be performed with an excellent outcome and long-term survival in reference centers. The surgical technique used for MV repair depends on the pathological mechanism, the morphological dimensions of the MV, the operative risk and the expertise of the cardiac surgeon. The surgical and interventional treatment of secondary MVVR is the subject of on-going discussions. In patients with moderate secondary MVR undergoing coronary artery bypass grafting, concomitant MV repair should be performed. In the presence of severe secondary MR with risk factors for failure of MV repair, patients should consider having MV replacement. In the rare cases of patients presenting with mitral valve stenosis (MVS) MV repair can be considered in young patients and who are most often treated with MV replacement. The choice between biological or mechanical MV replacement depends on the pathophysiology, the comorbidities, the amount of anticoagulation necessary and the age of the patient. New percutaneous techniques for MV replacement offer new treatment options for reoperation in high-risk patients.

show abstract